×
Back to Agenda
S37 : Recent Phase I Cancer Trial Design and Practice
Session Chair(s)
Takashi Asakawa, PHD
Group Manager, Biometrics Dept., Chugai Pharmaceuticals Co,.Ltd, Japan
Speaker(s)
Akihiro Hirakawa, PHD
Professor, Department of Clinical Biostatistics, Institute of Science Tokyo, Japan
KENTARO TAKEDA, PHD
Head of innovative statistical science, Astellas Pharma Global Development, Inc., United States
Mie Suzuki, MPH
Oncology, Clinical Research, Pfizer R&D Japan G.K., Japan
Kaito Takahashi
, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Joji Mori, PHD
Sr. Advisor, Global Statistical Science Japan, Eli Lilly Japan K.K., Japan
Have an account?